Stasinos Sikalias

INTRODUCTORY SECTION

Welcome to my personal website.

I am a pharmacist, founder of Sikalias Pharmacy and CEO of Sikalias Pharmaceutical Laboratories. My scientific and professional work sits at the intersection of community pharmacy, evidence-based compounding, formulation science and health product development.

Through Sikalias Pharmacy and Sikalias Pharmaceutical Laboratories, I work with a common focus on quality, stability, documentation and the conversion of real therapeutic and market needs into practical solutions for patients, physicians, pharmacies and healthcare companies.

In my daily practice, many compounded prescriptions are not simply preparations. They are formulation challenges that require compatibility assessment, dosage-form design, preservation strategy, stability rationale and disciplined development workflow.

This exact perspective — from compounding to formulation — also informs my work at Sikalias Pharmaceutical Laboratories, where development follows a full cycle from brief and formulation to pilot work, stability and technical dossier preparation.

AREAS OF EXPERTISE

• Pharmaceutical compounding and individualized dosage forms
• Formulation development and product optimization
• Stability, compatibility and dosage-form selection
• Documentation, quality mindset and practical QA/QC thinking
• Product development for pharmaceuticals, nutraceuticals, medical devices, FSMPs and cosmetics
• Scientific speaking, training and applied pharmacy practice

BIOGRAPHY

• Born in Athens in 1972.
• Graduated from the Faculty of Pharmacy, National and Kapodistrian University of Athens, in 1995.
• Completed military service during 1995–1997.
• Attended postgraduate studies in Biopharmaceutics and Pharmacokinetics during 1997–1999.
• In 1998, I founded Sikalias Pharmacy, continuing my family’s pharmacy heritage that began in 1967.
• Since 2000, I have specialized in pharmaceutical compounding and in an evidence-based approach to individualized preparations.
• In 2003, I began developing natural dermocosmetics under the Kallio brand.
• In 2012, I launched the laboratory and development activity that evolved into today’s Sikalias Pharmaceutical Laboratories.
• In 2016, I undertook a coordinating role in the National Compounding Committee of IDEEAF and the Panhellenic Pharmaceutical Association.
• In 2017, a major upgrade of the production and R&D infrastructure was completed.
• In 2025, a second support site was added in the Peristeri Industrial Area.

CLOSING / COLLABORATIONS

My strongest interests include scientific collaborations, speaking engagements, healthcare professional training and projects where knowledge of compounding, formulation and documentation can be translated into real clinical and business value.